We observed that thapsigargin (TG), a non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase, induced robust expression of IL-8, which can be associated with IL-8 mediated cancer cell survival. The gene discussed is ATP2A3; the disease is cancer.